Related Experiment Video
Updated: Dec 20, 2025
07:41
Echocardiographic Evaluation of Atrial Communications before Transcatheter Closure
Published on: February 8, 2022
4.2K
Tricuspid atresia: Where are we now?
Anoop S Sumal1, Harry Kyriacou1, Ahmed M H A M Mostafa1
1School of Clinical Medicine, Addenbrooke's Hospital, University of Cambridge, Cambridge, UK.
Journal of Cardiac Surgery
|June 3, 2020
Summary
Tricuspid atresia (TA) is a severe congenital heart defect requiring prompt diagnosis and surgical palliation. This review covers TA
Area of Science:
- Pediatric Cardiology
- Congenital Heart Disease
- Neonatal Medicine
Background:
- Tricuspid atresia (TA) is a critical congenital heart defect.
- It presents with cyanosis in newborns and is fatal without intervention.
- Management involves complex, multi-stage surgical palliation.
Purpose of the Study:
- To review the pathophysiology, presentation, and classification of TA.
- To discuss current evidence for medical and surgical treatments.
- To highlight recent case reports and future research directions.
Main Methods:
- Literature review of pathophysiology, clinical presentation, and diagnostics.
- Analysis of evidence supporting current treatment strategies.
- Inclusion of recent case reports and emerging research.
Main Results:
- TA necessitates early recognition and surgical intervention for survival.
- Current management relies on staged palliative procedures.
- Etiology and optimal pharmacotherapy require further investigation.
Conclusions:
- Timely diagnosis and surgical palliation are crucial for infants with TA.
- Further research is needed to understand TA etiology and refine treatment protocols.
- Optimizing surgical management remains a key goal.
More Related Videos
Related Concept Videos
01:23Mitral Stenosis II: Clinical features and Diagnostic Tests
142
Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
142
01:22Mitral Stenosis I: Introduction
254
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
254
01:27Development of the Heart
1.8K
The development of the human heart, a crucial organ, commences from the mesoderm on the 18th or 19th day after fertilization. This process initiates in the cardiogenic area, a group of mesodermal cells at the embryo's head end, which evolves into elongated strands known as cardiogenic cords. These cords undergo a transformation to form hollow-centered endocardial tubes.
As the embryo undergoes lateral folding, these paired tubes approach each other, merging into a single primitive heart...
As the embryo undergoes lateral folding, these paired tubes approach each other, merging into a single primitive heart...
1.8K
01:22Mitral Valve Prolapse II: Assessment and Management
255
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
255
01:22Aortic Regurgitation II: Clinical Features and Diagnostic Tests
278
Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
278
01:20Mitral Regurgitation I: Introduction
262
Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
262